ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BMS Completes Sale of Couvet Site to WuXi STA
August 05, 2021Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Couvet, Switzerland, to WuXi STA, a subsidiary of WuXi AppTec. -
WuXi STA completes acquisition of its first European facility
August 05, 2021The purchase of BMS's Couvet, Switzerland facility adds commercial-scale production capacity for capsule and tablet dosage forms -
WuXi STA Completes Acquisition of BMS Manufacturing Facility
August 04, 2021State-of-the-art facility in Couvet, Switzerland enhances WuXi STA's drug product capacity in Europe. -
WuXi STA to buy Swiss pharma manufacturing facility from Bristol Myers Squibb
February 07, 2021WuXi STA, a subsidiary of Chinese pharmaceutical company WuXi AppTec, has agreed to buy the Couvet, Switzerland-based manufacturing facility from Bristol Myers Squibb.
Pharma Sources Insight January 2025
